Top Markets
Coin of the day
Lipum AB (publ) Lipum AB (publ)

Lipum AB (publ)

LIPUM
Rang in aandelen #27261
Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on... Lipum AB (publ) is a biopharmaceutical firm based in Sweden, focused on pioneering the discovery and development of therapeutic solutions for long-term inflammatory conditions. The company's primary therapeutic asset, SOL-116, is a humanized antibody currently in the late preclinical stage, designed to treat pediatric rheumatism and adult rheumatoid arthritis. To facilitate the advancement of SOL-116 into clinical trials, Lipum has established a collaboration with Pelago Bioscience AB to meticulously monitor drug targets. Founded in 2010, the company's operations are headquartered in Umeå, Sweden.
Aandeelprijs
$1.60
Laatst gesynchroniseerd: 2026-03-18
Marktkapitalisatie
$34.00M
Verandering (1 dag)
0.70%
Verandering (1 jaar)
2.50%
Land
SE
Handel Lipum AB (publ) (LIPUM)

Categorie

Dividendrendementgeschiedenis voor Lipum AB (publ) (LIPUM)
Het dividendrendement (TTM) van Lipum AB (publ) (aandelsymbool: LIPUM) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Lipum AB (publ) (LIPUM) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH